Cambridge Investment Research Advisors’s BP Midstream Partners LP Common Units representing Limited Partner Interests BPMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-27,970
Closed -$473K 3289
2022
Q1
$473K Buy
27,970
+4,256
+18% +$74.3K ﹤0.01% 2151
2021
Q4
$363K Buy
23,714
+2,985
+14% +$40.4K ﹤0.01% 2360
2021
Q3
$275K Sell
20,729
-650
-3% -$8.75K ﹤0.01% 2539
2021
Q2
$310K Buy
21,379
+425
+2% +$5.89K ﹤0.01% 2449
2021
Q1
$265K Sell
20,954
-6,792
-24% -$83.1K ﹤0.01% 2376
2020
Q4
$294K Buy
27,746
+921
+3% +$9.64K ﹤0.01% 2160
2020
Q3
$266K Buy
+26,825
New +$294K ﹤0.01% 2032

Cambridge Investment Research Advisors's BPMP Position: Q2 2022 in Review

Cambridge Investment Research Advisors sold out of BP Midstream Partners LP Common Units representing Limited Partner Interests (BPMP) in Q2 2022, closing a stake of 27,970 shares — an estimated $473K sold.

Cambridge Investment Research Advisors first reported a position in BPMP in Q3 2020 and held it in 7 quarters. The position peaked at $473K in Q1 2022. 0 funds tracked by Wall St. Rank hold BPMP as of Q2 2022.

  • Cambridge Investment Research Advisors reported no remaining BP Midstream Partners LP Common Units representing Limited Partner Interests position as of Q2 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 27,970 BP Midstream Partners LP Common Units representing Limited Partner Interests shares in Q2 2022, an estimated $473K.
  • Cambridge Investment Research Advisors first reported a position in BP Midstream Partners LP Common Units representing Limited Partner Interests in Q3 2020 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's BP Midstream Partners LP Common Units representing Limited Partner Interests position peaked at $473K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BP Midstream Partners LP Common Units representing Limited Partner Interests as of Q2 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.